InduPro Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $77M

  • Investors
  • 10

InduPro General Information

Description

Operator of a biopharma company intended to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates. The company's platform integrates inherent protein proximity at the cell surface and translates biological insights into transformative therapeutics, enabling patients to receive therapies through novel cell-surface platform technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1930 Boren Avenue
  • Suite 200
  • Seattle, WA 98101
  • United States
+1 (206)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1930 Boren Avenue
  • Suite 200
  • Seattle, WA 98101
  • United States
+1 (206)

InduPro Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InduPro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 12-Aug-2026 $77M Completed Pre-Clinical Trials
3. Early Stage VC 10-Dec-2025 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 13-Jun-2024 $85M $85M Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Sep-2022 Completed Pre-Clinical Trials
To view InduPro’s complete valuation and funding history, request access »

InduPro Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view InduPro’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

InduPro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharma company intended to manipulate protein pairings via induced protein proximity to create novel si
Drug Discovery
Seattle, WA
49 As of 2024

Barcelona, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InduPro Competitors (1)

One of InduPro’s competitors is Ahead Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ahead Therapeutics Venture Capital-Backed Barcelona, Spain
You’re viewing 1 of 1 competitors. Get the full list »

InduPro Patents

InduPro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026235748-A1 Detuned anti-human serum albumin (hsa) antibodies Pending 05-May-2025
WO-2026136599-A1 Bivalent antibodies comprising anti-egfr and anti-cdcp1 antibody regions Pending 17-Dec-2024
WO-2026136456-A1 Multivalent antibodies comprising anti-pd-1 and anti-cd2 antibody regions Pending 16-Dec-2024
WO-2026122956-A1 Bivalent antibodies comprising anti-pd-1 and anti-cd6 antibody regions Pending 06-Dec-2024 C07K16/2818

InduPro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InduPro Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eli Lilly and Company Foundation Limited Partner Minority
Lilly USA Corporation Minority
Solasta Ventures Venture Capital Minority
Sanofi Corporation Minority
Emerson Collective Impact Investing Minority
You’re viewing 5 of 10 investors. Get the full list »

InduPro FAQs

  • When was InduPro founded?

    InduPro was founded in 2022.

  • Where is InduPro headquartered?

    InduPro is headquartered in Seattle, WA.

  • What is the size of InduPro?

    InduPro has 49 total employees.

  • What industry is InduPro in?

    InduPro’s primary industry is Drug Discovery.

  • Is InduPro a private or public company?

    InduPro is a Private company.

  • What is InduPro’s current revenue?

    The current revenue for InduPro is .

  • How much funding has InduPro raised over time?

    InduPro has raised $162M.

  • Who are InduPro’s investors?

    Eli Lilly and Company Foundation, Lilly USA, Solasta Ventures, Sanofi, and Emerson Collective are 5 of 10 investors who have invested in InduPro.

  • Who are InduPro’s competitors?

    Ahead Therapeutics is a competitor of InduPro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process